a
DePuy Synthes Spine parent company Johnson & Johnson reported the acquisition of Synthes and subsequent divestiture of the DePuy trauma business contributed to a 5.7 percent worldwide operational sales growth in the first quarter of 2013.
The New Jersey Health Foundation received a $2 million endowment in honor of the late orthopedist Fred Behrens, MD.
Medical device manufacturer Synthes USA has filed a civil action claim against a former employee, saying the man violated his contract, according to The Pennsylvania Record.
A German District Court in Mannheim has dismissed Synthes' patent infringement claims against Spinal Kinetics, and the court ordered Synthes to pay certain litigation costs.
The European Commission has approved Johnson & Johnson's $21.3 billion acquisition of Synthes.
Emerge Medical CEO John Marotta, who previously served as a sales representative for Synthes, recently filed a counterclaim against Synthes alleging antitrust violations, according to a Mass Device report.
Synthes announced it signed a license and development agreement with Kuros to commercialize Kuros' synthetic matrix technology.
Johnson & Johnson recently made concessions to convince the European Union's antitrust regulator that it's acquisition of Swiss company Synthes is clear of any issues, according to a New York Times report.
Synthes reported full year earnings at $966.8 million, a 6.5 percent increase over 2010, according to a company news release.
Synthes, a Swiss spine device company currently in the middle of being acquired by Johnson & Johnson, recently filed suit against three former sales representatives and Stryker for breaching company loyalty, according to a Philadelphia Inquirer news report.
  • «
  •  Prev 
  •  1 
  •  2 
  •  3 
  •  Next 
  • »
Page 1 of 3